Service Description

The Prostate Health Index (PHI) is a blood test that combines multiple PSA measurements to provide a more accurate assessment of prostate cancer risk compared to standard PSA testing alone. Why it’s done: To assess risk of prostate cancer To help guide decisions about the need for a prostate biopsy To monitor men with elevated PSA levels To support early detection and proactive prostate health management To reduce unnecessary biopsies in low-risk patients Specimen Type: Blood draw Turnaround Time: Typically 3–5 business days Collection Available: In-office or mobile blood draw services